Karyotype or Chromosome analysis is a test that evaluated the number and structure of a person’s chromosome in order to detect abnormalities. Chromosome are thread like structures within each nucleus and contain the body’s genetic blueprint. Each chromosome contains thousands of genes in specific locations. These genes are responsible for person’s inherited physical characteristics and they have a profound impact on growth, development and function.

Read More

Non-invasive prenatal screening (NIPS) offers high-risk obstetric patients a noninvasive way to determine the risk of birth defects through a blood test. This is achieved by measuring traces of fetal DNA found in maternal blood; the test can detect fetal aneuploidies with excellent accuracy across all common fetal chromosomal abnormalities. Provides invaluable insight to patient for taking informed decisions with regard to electing CVS or amniocentesis (invasive) versus Non-invasive prenatal screening (NIPS) method

Read More

Chromosomal microarray (CMA) testing looks for extra (duplicated) or missing (deleted) chromosomal segments, sometimes called copy number variants (CNVs). These include microdeletions and micro-duplications of chromosome segments, which are too small to see under a microscope but may contain multiple genes. Chromosome microarray will detect most abnormalities of chromosome number (trisomy, monosomy, etc.) including Down syndrome and balanced rearrangements of chromosome structure (translocations, etc.)

Read More
Most Read Blogs

CYTOGeNeOM ADMIN 9 August

CYTOGeNeOM Doctors
CYTOGeNeOM Facebook Updates
Page 1 of 6    1 2 3 4 ... 6 Next > Last >|

As a company we believe in philosophy of adoption of advanced genetics technologies with clinical annotation (medical knowledge) that can improve clinical outcomes for patients. This approach has already been proved beneficial for patient’s undergoing diagnosis.

Copyright © 2021 CYTOGeNeOM

Powered by CYTOGeNeOM